MoneyWorks4Me

Medicamen Biotech - Quaterly Results

13 Aug 2024 Evaluate
The company's total revenue for the quarter ended June 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 414.82 millions.A big decline of -48.91% was reported for the quarter ended June 2024 to Rs. 22.57  millions from Rs. 44.18 millions of corresponding previous quarter.Operating profit for the quarter ended June 2024 decreased to 54.35 millions as compared to 77.91 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 414.82 405.03 2.42 414.82 405.03 2.42 1723.86 1378.84 25.02
Other Income 5.75 3.79 51.72 5.75 3.79 51.72 23.03 24.62 -6.46
PBIDT 54.35 77.91 -30.24 54.35 77.91 -30.24 282.74 266.09 6.26
Interest 6.78 9.57 -29.15 6.78 9.57 -29.15 43.77 29.23 49.74
PBDT 47.57 68.34 -30.39 47.57 68.34 -30.39 238.97 236.86 0.89
Depreciation 17.42 16.80 3.69 17.42 16.80 3.69 70.08 63.54 10.29
PBT 30.15 51.54 -41.50 30.15 51.54 -41.50 168.89 173.32 -2.56
TAX 7.58 7.36 2.99 7.58 7.36 2.99 35.90 23.31 54.01
Deferred Tax -0.78 -5.10 -84.71 -0.78 -5.10 -84.71 -6.27 -13.69 -54.20
PAT 22.57 44.18 -48.91 22.57 44.18 -48.91 132.99 150.01 -11.35
Equity 127.15 126.51 0.51 127.15 126.51 0.51 127.15 126.51 0.51
PBIDTM(%) 13.10 19.24 -31.89 13.10 19.24 -31.89 16.40 19.30 -15.01
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..